Biosimilars and Biologics

Journal Subjects
  • Active Substance

  • Adverse Event

  • Amino Acid

  • Anaemia

  • Anaphylaxis

  • Antibody

  • Antigen

  • Aplasia

  • Assay

  • Autoimmune Disease

  • Autoimmunity

  • Bacteria

  • Bioassay

  • Bioavailability

  • Bioequivalence

  • Biological Medicinal

  • Biopharmaceuticals

  • Biosimilar

  • Biosimilarity

  • Biotechnology

  • Cell culture

  • Chemotherapy

  • Comparability

  • Diabetes

  • DNA (Deoxyribonucleic Acid)

  • Enzyme

  • Erythropoietin (epoetin – EPO)

  • EudraVigilance

  • Fermentation

  • Generic Medicinal

  • Genetic Disorder

  • Genetic Engineering

  • Glycosylation

  • Haemoglobin

  • Harvesting

  • Immune System

  • Immunogenic/Immunogenicity

  • Insulin

  • Interchangeability

  • Molecular

  • Molecule

  • Monoclonal Antibody

  • Non-biological Complex Drug (NBCD)

  • Neurodegenerative

  • Nucleic Acid

  • Organism

  • Pharmaceutical Medicine

  • Pharmacodynamics

  • Pharmacokinetics

  • Pharmacovigilance

  • Polypeptides

  • Proteins

  • RNA (Ribonucleic Acid)

  • Therapeutic Equivalent

  • Second-Generation Biological

  • Traceability

  • Vaccine